Dr. Hönle AG supplies industrial UV technologies and systems worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||€40.50|
|52 Week High||€38.30|
|52 Week Low||€58.10|
|1 Month Change||-5.70%|
|3 Month Change||-16.84%|
|1 Year Change||-19.00%|
|3 Year Change||-38.64%|
|5 Year Change||58.36%|
|Change since IPO||134.24%|
Recent News & Updates
Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Dr. Hönle AG ( ETR:HNL...
Is Dr. Hönle (ETR:HNL) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?
Dr. Hönle AG ( ETR:HNL ), is not the largest company out there, but it received a lot of attention from a substantial...
|HNL||DE Electrical||DE Market|
Return vs Industry: HNL underperformed the German Electrical industry which returned 19.2% over the past year.
Return vs Market: HNL underperformed the German Market which returned 24.4% over the past year.
Stable Share Price: HNL is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: HNL's weekly volatility (5%) has been stable over the past year.
About the Company
Dr. Hönle AG supplies industrial UV technologies and systems worldwide. It operates through three segments: Equipment & Systems, Glass & Lamps, and Adhesives. The Equipment & Systems segment offers LED UV units, UV equipment/UV systems/UV units, IR units, inert systems, UV disinfection systems, solar simulation systems and light fixtures, lighting systems, UV measuring technology products, and components and replacement parts.
Dr. Hönle Fundamentals Summary
|HNL fundamental statistics|
Is HNL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HNL income statement (TTM)|
|Cost of Revenue||€40.10m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Feb 22, 2022
|Earnings per share (EPS)||0.93|
|Net Profit Margin||5.28%|
How did HNL perform over the long term?See historical performance and comparison
1.2%Current Dividend Yield
Is Dr. Hönle undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: HNL (€40.5) is trading below our estimate of fair value (€163.83)
Significantly Below Fair Value: HNL is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: HNL is good value based on its PE Ratio (43.4x) compared to the German Electrical industry average (50.5x).
PE vs Market: HNL is poor value based on its PE Ratio (43.4x) compared to the German market (22.6x).
Price to Earnings Growth Ratio
PEG Ratio: HNL is good value based on its PEG Ratio (0.8x)
Price to Book Ratio
PB vs Industry: HNL is good value based on its PB Ratio (2.1x) compared to the DE Electrical industry average (3.7x).
How is Dr. Hönle forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HNL's forecast earnings growth (53.8% per year) is above the savings rate (-0.01%).
Earnings vs Market: HNL's earnings (53.8% per year) are forecast to grow faster than the German market (12.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: HNL's revenue (8% per year) is forecast to grow faster than the German market (5.9% per year).
High Growth Revenue: HNL's revenue (8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HNL's Return on Equity is forecast to be low in 3 years time (13.7%).
How has Dr. Hönle performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HNL has high quality earnings.
Growing Profit Margin: HNL's current net profit margins (5.3%) are lower than last year (8.1%).
Past Earnings Growth Analysis
Earnings Trend: HNL's earnings have declined by 6.6% per year over the past 5 years.
Accelerating Growth: HNL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: HNL had negative earnings growth (-29.1%) over the past year, making it difficult to compare to the Electrical industry average (-6.4%).
Return on Equity
High ROE: HNL's Return on Equity (4.9%) is considered low.
How is Dr. Hönle's financial position?
Financial Position Analysis
Short Term Liabilities: HNL's short term assets (€88.2M) exceed its short term liabilities (€26.7M).
Long Term Liabilities: HNL's short term assets (€88.2M) exceed its long term liabilities (€67.5M).
Debt to Equity History and Analysis
Debt Level: HNL's debt to equity ratio (42.9%) is considered high.
Reducing Debt: HNL's debt to equity ratio has increased from 16.8% to 42.9% over the past 5 years.
Debt Coverage: HNL's debt is not well covered by operating cash flow (9.6%).
Interest Coverage: HNL's interest payments on its debt are well covered by EBIT (9.6x coverage).
What is Dr. Hönle current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: HNL's dividend (1.23%) is higher than the bottom 25% of dividend payers in the German market (0.99%).
High Dividend: HNL's dividend (1.23%) is low compared to the top 25% of dividend payers in the German market (3.23%).
Stability and Growth of Payments
Stable Dividend: HNL's dividend payments have been volatile in the past 10 years.
Growing Dividend: HNL's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (49.3%), HNL's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: HNL's dividends in 3 years are forecast to be well covered by earnings (38.3% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Dr. Hönle has no CEO, or we have no data on them.
Experienced Board: HNL's board of directors are considered experienced (6.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10%.
Dr. Hönle AG's employee growth, exchange listings and data sources
- Name: Dr. Hönle AG
- Ticker: HNL
- Exchange: XTRA
- Founded: 1976
- Industry: Electrical Components and Equipment
- Sector: Capital Goods
- Market Cap: €245.505m
- Shares outstanding: 6.06m
- Website: https://www.hoenle.de
Number of Employees
- Dr. Hönle AG
- Lochhamer Schlag 1
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/21 20:56|
|End of Day Share Price||2021/10/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.